{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:03:30Z","timestamp":1791306210113,"version":"4.3.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report about new apoptotic and non-apoptotic death pathways in neutrophils that are initiated via the surface molecule sialic acid-binding immunoglobulin-like lectin (Siglec)-9. In normal neutrophils, Siglec-9 ligation induced apoptosis. Inflammatory neutrophils obtained from patients with acute septic shock or rheumatoid arthritis demonstrated increased Siglec-9, but normal Fas receptor-mediated cytotoxic responses when compared with normal blood neutrophils. The increased Siglec-9-mediated death was mimicked in vitro by short-term preincubation of normal neutrophils with proinflammatory cytokines, such as granulocyte\/macrophage colony-stimulating factor (GM-CSF), interferon-\u03b1 (IFN-\u03b1), and IFN-\u03b3, and was demonstrated to be caspase independent. Experiments using scavengers of reactive oxygen species (ROS) or neutrophils unable to generate ROS indicated that both Siglec-9-mediated caspase-dependent and caspase-independent forms of neutrophil death depend on ROS. Interestingly, the caspase-independent form of neutrophil death was characterized by cytoplasmic vacuolization and several other nonapoptotic morphologic features, which were also seen in neutrophils present in joint fluids from rheumatoid arthritis patients. Taken together, these data suggest that apoptotic (ROS- and caspase-dependent) and nonapoptotic (ROS-dependent) death pathways are initiated in neutrophils via Siglec-9. The new insights have important implications for the pathogenesis, diagnosis, and treatment of inflammatory diseases such as sepsis and rheumatoid arthritis. (Blood. 2005;106:1423-1431)<\/jats:p>","DOI":"10.1182\/blood-2004-10-4112","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T01:05:31Z","timestamp":1113354331000},"page":"1423-1431","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":192,"title":["Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment"],"prefix":"10.1182","volume":"106","author":[{"given":"Stephan","family":"von Gunten","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shida","family":"Yousefi","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Seitz","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan M.","family":"Jakob","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schaffner","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Seger","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Takala","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Villiger","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Uwe","family":"Simon","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, the Department of Rheumatology\/Clinical Immunology\/Allergology, the Department of Intensive Care Medicine, and the Department of Pathology, University Hospital Bern; and University Children's Hospital of Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219353594400_REF1","doi-asserted-by":"crossref","unstructured":"Colotta F, Re F, Polantarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood.1992;80: 2012-2020.","DOI":"10.1182\/blood.V80.8.2012.2012"},{"key":"2020021219353594400_REF2","doi-asserted-by":"crossref","unstructured":"Dibbert B, Weber M, Nikolaizik WH, et al. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci USA.1999;96: 13330-13335.","DOI":"10.1073\/pnas.96.23.13330"},{"key":"2020021219353594400_REF3","doi-asserted-by":"crossref","unstructured":"Maianski NA, Mul FPJ, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood.2002;99: 672-679.","DOI":"10.1182\/blood.V99.2.672"},{"key":"2020021219353594400_REF4","doi-asserted-by":"crossref","unstructured":"Brach MA, deVos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood.1992;80: 2920-2924.","DOI":"10.1182\/blood.V80.11.2920.2920"},{"key":"2020021219353594400_REF5","doi-asserted-by":"crossref","unstructured":"Lee A, Whyte MKB, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol.1993;54: 283-288.","DOI":"10.1002\/jlb.54.4.283"},{"key":"2020021219353594400_REF6","doi-asserted-by":"crossref","unstructured":"Baumann R, Casaulta C, Simon D, Conus S, Yousefi S, Simon HU. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J.2003;17: 2221-2230.","DOI":"10.1096\/fj.03-0110com"},{"key":"2020021219353594400_REF7","doi-asserted-by":"crossref","unstructured":"Iwai K, Miyawaki T, Takizawa T, et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood.1994;84: 1201-1208.","DOI":"10.1182\/blood.V84.4.1201.1201"},{"key":"2020021219353594400_REF8","doi-asserted-by":"crossref","unstructured":"Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med.1996;183: 1407-1414.","DOI":"10.1084\/jem.183.4.1407"},{"key":"2020021219353594400_REF9","doi-asserted-by":"crossref","unstructured":"Hebestreit H, Yousefi S, Balatti I, et al. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol.1996;26: 1775-1780.","DOI":"10.1002\/eji.1830260817"},{"key":"2020021219353594400_REF10","doi-asserted-by":"crossref","unstructured":"Simon HU, Yousefi S, Dibbert B, et al. Role for tyrosine phosphorylation and Lyn tyrosine kinase in Fas receptor-mediated apoptosis in eosinophils. Blood.1998;92: 547-557.","DOI":"10.1182\/blood.V92.2.547"},{"key":"2020021219353594400_REF11","doi-asserted-by":"crossref","unstructured":"Crocker PR, Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol.2001;22: 337-342.","DOI":"10.1016\/S1471-4906(01)01930-5"},{"key":"2020021219353594400_REF12","doi-asserted-by":"crossref","unstructured":"Crocker PR, Mucklow S, Bouckson V, et al. Sialoadhesin, a macrophage sialic acid binding receptor for hematopoietic cells with 17 immunoglobulin-like domains. EMBO J.1994;13: 4490-4503.","DOI":"10.1002\/j.1460-2075.1994.tb06771.x"},{"key":"2020021219353594400_REF13","doi-asserted-by":"crossref","unstructured":"Stamenkovic I, Seed B. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature.1990;345: 74-77.","DOI":"10.1038\/345074a0"},{"key":"2020021219353594400_REF14","doi-asserted-by":"crossref","unstructured":"Kikly KK, Bochner BS, Freeman S, et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol.2000;105: 1093-1100.","DOI":"10.1067\/mai.2000.107127"},{"key":"2020021219353594400_REF15","doi-asserted-by":"crossref","unstructured":"Zhang JQ, Nicoll G, Jones C, Crocker PR. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human leukocytes. J Biol Chem.2000;275: 22121-22126.","DOI":"10.1074\/jbc.M002788200"},{"key":"2020021219353594400_REF16","doi-asserted-by":"crossref","unstructured":"Angata T, Varki A. Cloning, characterization, and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs. J Biol Chem.2000;275: 22127-22135.","DOI":"10.1074\/jbc.M002775200"},{"key":"2020021219353594400_REF17","doi-asserted-by":"crossref","unstructured":"Yousefi S, Green DR, Blaser K, Simon HU. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci U S A.1994;91: 10868-10872.","DOI":"10.1073\/pnas.91.23.10868"},{"key":"2020021219353594400_REF18","doi-asserted-by":"crossref","unstructured":"Altznauer F, Martinelli S, Yousefi S, et al. Inflammation-associated cell-cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med.2004;199: 1343-1354.","DOI":"10.1084\/jem.20032033"},{"key":"2020021219353594400_REF19","doi-asserted-by":"crossref","unstructured":"Razi N, Varki A. Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiol.1999;9: 1225-1234.","DOI":"10.1093\/glycob\/9.11.1225"},{"key":"2020021219353594400_REF20","doi-asserted-by":"crossref","unstructured":"Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet.1991;338: 720-722.","DOI":"10.1016\/0140-6736(91)91443-X"},{"key":"2020021219353594400_REF21","doi-asserted-by":"crossref","unstructured":"Walrand S, Valeix S, Rodriguez C, Ligot P, Chassagne J, Vasson MP. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes. Clin Chim Acta.2003;331: 103-110.","DOI":"10.1016\/S0009-8981(03)00086-X"},{"key":"2020021219353594400_REF22","doi-asserted-by":"crossref","unstructured":"Daigle I, Yousefi S, Colonna M, Green DR, Simon HU. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med.2002;8: 61-67.","DOI":"10.1038\/nm0102-61"},{"key":"2020021219353594400_REF23","doi-asserted-by":"crossref","unstructured":"Kim J, Schimming A, Kita H. Ligation of Fc\u03b3RII (CD32) pivotally regulates survival of human eosinophils. J Immunol.1999;162: 4253-4259.","DOI":"10.4049\/jimmunol.162.7.4253"},{"key":"2020021219353594400_REF24","doi-asserted-by":"crossref","unstructured":"Altznauer F, Conus S, Cavalli A, Folkers G, Simon HU. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem.2004;279: 5947-5957.","DOI":"10.1074\/jbc.M308576200"},{"key":"2020021219353594400_REF25","doi-asserted-by":"crossref","unstructured":"Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev.2003;193: 101-110.","DOI":"10.1034\/j.1600-065X.2003.00038.x"},{"key":"2020021219353594400_REF26","doi-asserted-by":"crossref","unstructured":"Daigle I, Simon HU. Critical role for caspases 3 and 8 in neutrophil but not eosinophil apoptosis. Int Arch Allergy Immunol.2001;126: 147-156.","DOI":"10.1159\/000049506"},{"key":"2020021219353594400_","doi-asserted-by":"crossref","unstructured":"Khwaja A, Tatton L. Caspase-mediated proteolysis and activation of protein kinase C\u03b4 plays a central role in neutrophil apoptosis. Blood.1999;94: 291-301.","DOI":"10.1182\/blood.V94.1.291.413k10_291_301"},{"key":"2020021219353594400_REF28","doi-asserted-by":"crossref","unstructured":"Pongracz J, Webb P, Wang K, Deacon E, Lunn OJ, Lord JM. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-\u03b4. J Biol Chem.1999;274: 37329-37334.","DOI":"10.1074\/jbc.274.52.37329"},{"key":"2020021219353594400_REF29","doi-asserted-by":"crossref","unstructured":"Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis.2000;5: 415-418.","DOI":"10.1023\/A:1009616228304"},{"key":"2020021219353594400_REF30","doi-asserted-by":"crossref","unstructured":"Keel M, Ungethum U, Steckholzer U, et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood.1997;90: 3356-3363.","DOI":"10.1182\/blood.V90.9.3356"},{"key":"2020021219353594400_REF31","doi-asserted-by":"crossref","unstructured":"Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol.1996;14: 397-440.","DOI":"10.1146\/annurev.immunol.14.1.397"},{"key":"2020021219353594400_REF32","doi-asserted-by":"crossref","unstructured":"Paul SP, Taylor LS, Stansbury EK, McVicar DW. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood.2000;96: 483-490.","DOI":"10.1182\/blood.V96.2.483"},{"key":"2020021219353594400_REF33","doi-asserted-by":"crossref","unstructured":"Falco M, Biassoni R, Bottino C, et al. Identification and molecular cloning of p75\/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med.1999;190: 793-802.","DOI":"10.1084\/jem.190.6.793"},{"key":"2020021219353594400_REF34","doi-asserted-by":"crossref","unstructured":"Nutku E, Aizawa H, Hudson SA, Bochner BS. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood.2003;101: 5014-5020.","DOI":"10.1182\/blood-2002-10-3058"},{"key":"2020021219353594400_REF35","doi-asserted-by":"crossref","unstructured":"Vitale C, Romagnani C, Puccetti A, et al. Surface expression and function of p75\/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells. Proc Natl Acad Sci U S A.2001;98: 5764-5769.","DOI":"10.1073\/pnas.091097198"},{"key":"2020021219353594400_REF36","doi-asserted-by":"crossref","unstructured":"Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen SH. SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem.1998;273: 3687-3694.","DOI":"10.1074\/jbc.273.6.3687"},{"key":"2020021219353594400_REF37","doi-asserted-by":"crossref","unstructured":"Klein JB, Rane MJ, Scherzer JA, et al. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J Immunol.2000;164: 4286-4291.","DOI":"10.4049\/jimmunol.164.8.4286"},{"key":"2020021219353594400_REF38","doi-asserted-by":"crossref","unstructured":"Yousefi S, Simon HU. SHP-1: a regulator of neutrophil apoptosis. Semin Immunol.2003;15: 195-199.","DOI":"10.1016\/S1044-5323(03)00033-2"},{"key":"2020021219353594400_REF39","doi-asserted-by":"crossref","unstructured":"Brumell JH, Chan CK, Butler J, et al. Regulation of Src homology 2-containing tyrosine phosphatase 1 during activation of human neutrophils. J Biol Chem.1997;272: 875-882.","DOI":"10.1074\/jbc.272.2.875"},{"key":"2020021219353594400_REF40","doi-asserted-by":"crossref","unstructured":"Tidow N, Kasper B, Welte K. SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 are dramatically increased at the protein level in neutrophils from patients with severe congenital neutropenia (Kostmann's syndrome). Exp Hematol.1999;27: 1038-1045.","DOI":"10.1016\/S0301-472X(99)00036-3"},{"key":"2020021219353594400_REF41","doi-asserted-by":"crossref","unstructured":"Dong Q, Siminovitch KA, Fialkow L, Fukushima T, Downey GP. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1. J Immunol.1999;162: 3220-3230.","DOI":"10.4049\/jimmunol.162.6.3220"},{"key":"2020021219353594400_REF42","doi-asserted-by":"crossref","unstructured":"Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ.2001;8: 569-581.","DOI":"10.1038\/sj.cdd.4400852"},{"key":"2020021219353594400_REF43","doi-asserted-by":"crossref","unstructured":"Maianski NA, Roos D, Kuijpers TW. Tumor necrosis factor induces a caspase-independent death pathway in human neutrophils. Blood.2003;101: 1987-1995.","DOI":"10.1182\/blood-2002-02-0522"},{"key":"2020021219353594400_REF44","doi-asserted-by":"crossref","unstructured":"Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med.1998;187: 1477-1485.","DOI":"10.1084\/jem.187.9.1477"},{"key":"2020021219353594400_REF45","doi-asserted-by":"crossref","unstructured":"Vercammen D, Brouckaert G, Denecker G, et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med.1998;188: 919-930.","DOI":"10.1084\/jem.188.5.919"},{"key":"2020021219353594400_REF46","doi-asserted-by":"crossref","unstructured":"Green DR, Ware CF. Fas ligand: privilege and peril. Proc Natl Acad Sci U S A.1997:94: 5986-5990.","DOI":"10.1073\/pnas.94.12.5986"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1423\/1712208\/zh801605001423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1423\/1712208\/zh801605001423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:28:59Z","timestamp":1683052139000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/4\/1423\/21533\/Siglec9-transduces-apoptotic-and-nonapoptotic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,15]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-10-4112","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,15]]}}}